The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for Y Wada


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
14
Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human 3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.EBI
Asahi Kasei Pharma
1
The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo.EBI
Riken Center For Life Science Technologies
6
Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.EBI
Kanebo
4
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.EBI
New Drug Research Laboratory
26
Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore.EBI
Takeda Pharmaceutical
23
Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.EBI
Vrije Universiteit
4
(Piperidinylalkoxy)chromones: novel antihistamines with additional antagonistic activity against leukotriene D4.EBI
Vrije Universiteit
48
Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.EBI
Vrije Universiteit
14
Discovery of Novel Indazole Derivatives as Orally AvailableβEBI
Asahi Kasei Pharma
100
PYRIMIDINES AND METHODS OF THEIR USEBDB
Kineta
15
Decarboxylase inhibitors for treating Parkinson's diseaseBDB
Sail Biomedicines
252
Pyrazole MAGL inhibitorsBDB
H. Lundbeck